BUPROPION HYDROCHLO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency award SPE2DP26P1186 was issued on September 17, 2026, to SZY Holdings, LLC for the procurement of Bupropion Hydrochloride medical supplies. Under solicitation SPE2DP-26-T-1590, the contract involves the supply of Teva Pharmaceuticals USA, Inc. part number NDC00591-3543-60, identified by national stock number 6505015056640. The purchase order specifies a total value of 1,399 dollars. Logistics requirements dictate that the supplies be shipped to a cross-dock facility in Baltimore, Maryland, for final delivery to Spangdahlem, Germany. The agreement adheres to the DLA Master Solicitation for eProcurement Automated Simplified Acquisitions and includes mandatory transportation control number requirements and critical shipping instructions.
General Info
Contract Value
$139.95Place of Performance
Not specifiedSet-Aside
Awardee
SZY HOLDINGS, LLCAward Issued Date
Documents
1AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
